Elephas Biosciences Corporation
Elephas Biosciences is developing an oncology imaging diagnostics platform to predict patient response to immunotherapy. The platform uses live patient biopsies to visualize immune cell activity and predict treatment response, aiming to improve the effectiveness and accessibility of cancer immunotherapies. This innovative approach addresses the significant challenge of predicting which patients will benefit from immunotherapy.
Buy Funded Startups lists
Funding Round: Series C
Funding Amount: $55M
Date: 23-Jan-2024
Investors: Venture Investors Health Fund, State of Wisconsin Investment Board (SWIB), Northpond Ventures, ARCH Ventures, Sands Capital, Moore Strategic Ventures, Tao Invest, WARF Ventures
Markets: Oncology, Immunotherapy, Diagnostics, Artificial Intelligence (AI), Biotechnology, Health Care, Health Diagnostics, Medical
HQ: Madison, Wisconsin, United States
Founded: 2020
Website: https://elephas.com/
LinkedIn: https://www.linkedin.com/company/elephasbiosciences/about/
Crunchbase: https://www.crunchbase.com/organization/elephas-biosciences
Leave a Comment
Comments
No comments yet.